Vimarsana
Biggest News Aggregation in the World

Page 6 - Classification Committee News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Classification Committee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Classification Committee Today - Breaking & Trending Today

Tonix Pharmaceuticals Enters into Agreement to Acquire Two FDA-Approved, Marketed Migraine Products from Upsher-Smith Laboratories, LLC - Tonix Pharmaceuticals (NASDAQ:TNXP) - Vimarsana News

Tonix Pharmaceuticals Enters into Agreement to Acquire Two FDA-Approved, Marketed Migraine Products from Upsher-Smith Laboratories, LLC - Tonix Pharmaceuticals (NASDAQ:TNXP)

Zembrace® SymTouch® (sumatriptan injection) and Tosymra® (sumatriptan nasal spray) are Indicated for the Treatment of Acute Migraine in Adults Strategic Acquisition Helps Build Tonix's Commercial

IPC and World Para Powerlifting saddened by the passing of Dr. Bassam Qasrawi - Vimarsana News

IPC and World Para Powerlifting saddened by the passing of Dr. Bassam Qasrawi

Former World Para Powerlifting Head of Classification received the highest distinction in the Paralympic Movement in 2019

Local Organising Committee for 2023 African Para-Games holds three-day retreat - Vimarsana News

Local Organising Committee for 2023 African Para-Games holds three-day retreat

The Local Organising Committee (LOC) for the 2023 African Para-Games has organized a three-day retreat for its directorates and sub-committee members. The retreat is to develop an action plan for the upcoming 1st African Para-Games in Ghana from September 3-13, 2023. It was also to finalise all unresolved assignments, develop…

BOLO issued for escaped inmates in Macon, Georgia - Vimarsana News

BOLO issued for escaped inmates in Macon, Georgia

BOLO issued for escaped inmates in Macon, Georgia. The BOLO was issued by the Georgia Department of Corrections.

Source: 13wmaz.com
U.S. FDA Approves QULIPTA® (atogepant) for Adults With Chronic Migraine - Vimarsana News

U.S. FDA Approves QULIPTA® (atogepant) for Adults With Chronic Migraine

QULIPTA® now the first and only oral CGRP receptor antagonist approved to prevent migraine across frequencies, including episodic and chronic Expanded...